Discovery of a Stress-Activated Protein Kinase Inhibitor for Lymphatic Filariasis-Reference-Cited by-同舟云学术

Discovery of a Stress-Activated Protein Kinase Inhibitor for Lymphatic Filariasis

Published:2018-02-09 Issue:3 Volume:9 Page:210-214
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Tummalapalli Sreedhar R.¹,Bhat Rohit¹,Chojnowski Agnieszka¹,Prorok Monika¹,Kreiss Tamara¹,Goldberg Ronald¹,Canan Stacie²,Hawryluk Natalie²,Mortensen Deborah²,Khetani Vikram³,Zeldis Jerome³,Siekierka John J.¹,Rotella David P.¹^ORCID

Affiliation:

1. Sokol Institute for Pharmaceutical Life Sciences and Department of Chemistry and Biochemistry, Montclair State University, Montclair, New Jersey 07043, United States

2. Celgene Global Health, Celgene San Diego, 10300 Campus Point Drive, San Diego, California 92121, United States

3. Celgene Global Health, 86 Morris Avenue, Summit, New Jersey 07901, United States

Funder

Celgene

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.7b00477

Reference14 articles.

1. Immunopathogenesis of lymphatic filarial disease